To explore this hypothesis, we compared CMV-specific and WT1-specific T cells in peripheral blood of AML patients after transplantation to determine whether CMV-induced immune response impacts relapse development after allo-HSCT. This evidence concerns the gene WT1 and acute myeloid leukemia.